Basic Information
| LncRNA/CircRNA Name | AP000769.1 |
| Synonyms | NA |
| Region | GRCh38_11:65455258-65466720 |
| Ensemble | ENSG00000173727 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung squamous cell carcinoma |
| ICD-0-3 | C34 |
| Methods | qPCR etc. |
| Sample | cell line (SK, MES3) |
| Expression Pattern | down-regulated |
| Function Description | The expression levels of FN1 and lnc AP000769.1 2:11 were signif-icantly decreased in the celecoxib -treated group compared with the Control group. |
| Pubmed ID | 29512696 |
| Year | 2018 |
| Title | Identification of key genes and long non-coding RNAs in celecoxib-treated lung squamous cell carcinoma cell line by RNA-sequencing. |
External Links
| Links for AP000769.1 | GenBank HGNC NONCODE |
| Links for lung squamous cell carcinoma | OMIM COSMIC |